Lachance and colleagues demonstrated that the proliferation of cancer cells in a hypoxic microenvironment is driven by activation of the HIF2α pathway; resulting from naturally occurring defects in DNMT3a (Lachance et al., 2014). The gene discussed is EPAS1; the disease is cancer.